Sunday, 13 September 2026European Markets

Goldman Sachs exits consumer banking after $4B in losses, refocuses on institutional finance

Goldman Sachs has sold its Marcus loan portfolio, GreenSky platform, and Personal Financial Management unit while offloading the Apple Card program to JPMorgan by 2026. The Wall Street bank absorbed roughly $4 billion in consumer banking losses before pivoting to institutional finance through its new Capital Solutions Group and acquisitions of Industry Ventures and Innovator Capital Management in 2025.

Goldman Sachs exits consumer banking after $4B in losses, refocuses on institutional finance
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

Goldman Sachs has completed its retreat from consumer banking after accumulating approximately $4 billion in losses, selling Marcus loans in 2023, the GreenSky platform in 2024, and transferring the Apple Card program to JPMorgan in 2026. Creative Planning acquired Goldman's Personal Financial Management unit in 2023.

The exit contrasts sharply with Goldman's 2016 consumer banking launch. Mortgage loan origination costs at Fannie Mae and Freddie Mac average $13,000 per loan, illustrating the cost burden traditional banks face in retail operations. Specialized fintech firms and digital-native lenders operate with lower overhead structures.

Goldman formed its Capital Solutions Group in 2025 and acquired Industry Ventures and Innovator Capital Management the same year. The bank is consolidating around institutional clients, investment banking, and asset management—businesses where relationship complexity and deal size favor traditional investment banks over automated platforms.

European universal banks face similar pressure. Deutsche Bank, BNP Paribas, and UBS maintain both retail and institutional operations, but AI-driven cost advantages increasingly favor specialized players. Digital banks like N26 and Revolut handle routine retail transactions at lower cost per customer than traditional branches.

Goldman's strategic shift raises questions about European banking structure. Universal banking models rely on cross-subsidization between retail deposits and investment banking operations. If retail banking becomes structurally unprofitable for institutions lacking scale or digital efficiency, European banks may need to choose specialization.

EU banking competition could intensify as U.S. investment banks concentrate on institutional clients in Europe while fintech companies capture retail segments. Goldman's European operations focus on corporate advisory, capital markets, and wealth management for high-net-worth clients—areas less vulnerable to AI disruption than mass-market lending.

The pattern suggests a bifurcation: specialized fintech for standardized retail services versus relationship-driven banks for complex institutional finance. European regulators face challenges maintaining competitive retail banking markets if economies of scale and AI automation create winner-take-all dynamics favoring either massive digital platforms or niche institutional players.

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Chip Boom Lifts Semiconductors as Export-Control Gaps Persist
AI infrastructure demand is fueling a broad semiconductor rally — Broadcom's AI chip revenue and Q4 guidance, Amazon's custom silicon crossing a $25B annual run rate, and bullish analyst calls on Micron and Sandisk tied to a memory chip boom underestimated even by bulls — with ASML rallying on sympathy. That momentum runs alongside unresolved US-China tech tensions: Belgium's arrest of a suspect for stealing chip technology for China and a blacklisted Chinese firm still acquiring Nvidia's top AI chips show export-control enforcement lagging the pace of AI chip demand.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,280 source documents archived
Query this data → isubstrate.com